Rob V. D. V.
- Country
- Spain
- Department
- Oftalmología
Research Overview
Data & Insights
Has run more than one trial at 0 of 25 partner sites.
Specializations
Macular Degeneration
The investigator concentrates on both neovascular and atrophic forms of macular degeneration, addressing lesion growth, visual acuity preservation, and disease progression.
- Neovascular Age-related Macular Degeneration treatment strategies
- Geographic Atrophy inhibition and lesion control
- Combination therapy with anti‑VEGF agents
- Long‑term safety of intravitreal delivery systems
Clinical activity includes evaluation of novel intravitreal agents and sustained‑release platforms.
Diabetic Retinopathy and Macular Edema
Focus is placed on retinal vascular leakage and edema associated with diabetes, aiming to improve best‑corrected visual acuity outcomes.
- Anti‑VEGF comparators for diabetic macular edema
- Assessment of visual acuity change using ETDRS charts
- Safety monitoring of intraocular pressure
- Exploratory inflammatory cytokine profiling
Research integrates efficacy endpoints with safety surveillance in diabetic populations.
Dry Eye and Meibomian Gland Dysfunction
Investigations target tear film instability and glandular dysfunction, evaluating both pharmacologic and device‑based interventions.
- Symptom score reduction in dry eye disease
- Effectiveness of lid hygiene and artificial tears
- Adjunctive anti‑inflammatory agents
- Objective tear cytokine level changes
Clinical trials assess short‑term and sustained improvements in ocular surface health.
Corneal Healing and Neurotrophic Keratopathy
Work includes therapies that promote corneal epithelial regeneration and neurotrophic support, addressing persistent defects and nerve impairment.
- Topical ophthalmic solutions for neurotrophic keratopathy
- Gel formulations facilitating corneal re‑epithelialization
- Evaluation of healing duration ≥28 days
- Safety profiling of novel corneal agents
Study designs emphasize objective imaging assessments of epithelial closure.
Thyroid Eye Disease and Myopia Control
Research extends to orbital inflammatory disorders and refractive progression, exploring systemic inhibition and low‑dose atropine strategies.
- Complement component inhibition in chronic thyroid eye disease
- Subcutaneous dosing regimens for disease modulation
- Low‑concentration atropine for pediatric myopia progression
- Long‑term safety and tolerability assessments
These initiatives aim to mitigate tissue remodeling and visual axis changes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.